Document Detail


The effects of growth hormone treatment on health-related quality of life in children.
MedLine Citation:
PMID:  16582566     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND/AIMS: The effects of growth hormone deficiency (GHD) on linear growth in children are well documented, but there is less convincing evidence regarding the impact on health-related quality of life (QOL). We examined QOL in children aged 8-16 years with acquired GHD following treatment for malignancy (AGHD) or idiopathic GHD (IGHD) on commencing growth hormone treatment (GHT) over 6 months. We adopted a longitudinal design involving consecutive patients and their families attending clinic over an 18-month period. Mothers and children were invited to complete questionnaires before GHT (T1) and 6 months later (T2). METHODS: Mothers of 22 children (AGHD n = 14; IGHD n = 8) completed standardized measures of child QOL and behaviour. Children completed parallel measures of QOL, short-term memory tasks and fitness either in clinic or at the family home. RESULTS: For children with AGHD, QOL was significantly below population norms at T1 and improved over time. For children diagnosed with IGHD, QOL at T1 was below, but comparable with population norms. QOL improved over time, though not significantly. CONCLUSION: GHT is potentially valuable for improving QOL in children, especially in cases of AGHD. We conclude that benefits of GHT for QOL need to be evaluated independent of different diagnostic groups.
Authors:
L Sheppard; C Eiser; H A Davies; S Carney; S A Clarke; T Urquhart; M J Ryder; A Stoner; N P Wright; G Butler
Related Documents :
16077466 - Sex differences in the malnourished status of chinese children due to schistosomiasis i...
16161286 - The psychological outcome of constitutional delay of growth and puberty.
2816356 - Update on the kabi international growth study, april 1989.
17328706 - Children's intuitive mathematics: the development of knowledge about nonlinear growth.
22717046 - Evaluation of cardiac functions with doppler echocardiography in children with down syn...
11818296 - Knowledge of welfare reform program provisions among families of children with chronic ...
Publication Detail:
Type:  Journal Article     Date:  2006-03-30
Journal Detail:
Title:  Hormone research     Volume:  65     ISSN:  0301-0163     ISO Abbreviation:  Horm. Res.     Publication Date:  2006  
Date Detail:
Created Date:  2006-04-25     Completed Date:  2006-06-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0366126     Medline TA:  Horm Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  243-9     Citation Subset:  IM    
Affiliation:
CR-UK Child and Family Health Group, Department of Psychology, University of Sheffield, Sheffield, UK. l.sheppard@sheffield.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Body Constitution
Child
Female
Growth Disorders / drug therapy*,  etiology
Health Status Indicators
Hormone Replacement Therapy
Human Growth Hormone / therapeutic use*
Humans
Leukemia, Lymphoid / complications
Male
Quality of Life*
Questionnaires
Recombinant Proteins / therapeutic use
Chemical
Reg. No./Substance:
0/Recombinant Proteins; 12629-01-5/Human Growth Hormone
Comments/Corrections
Comment In:
Horm Res. 2006;65(5):250-2; discussion 252   [PMID:  16582567 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenital hyperthyroidism: the fetus as a patient.
Next Document:  Insulin allergy and extensive lipoatrophy in child with type 1 diabetes.